Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Jersey Mike's Subs Inc. Class A Common Stock (JMKE) vs Revolution Medicines Inc. Common Stock (RVMD) Price & Performance

Jersey Mike's Subs Inc. Class A Common StockTrade
Revolution Medicines Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Jersey Mike's Subs Inc. Class A Common Stock vs Revolution Medicines Inc. Common Stock — how do they compare? Jersey Mike's Subs Inc. Class A Common Stock trades at $16.95 (market cap $5.57B), while Revolution Medicines Inc. Common Stock trades at $193.15 (market cap $40.39B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 7.3× Jersey Mike's Subs Inc. Class A Common Stock's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, Jersey Mike's Subs Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Jersey Mike's Subs Inc. Class A Common Stock for 0 Days and Revolution Medicines Inc. Common Stock for 2 Days on average.

JMKERVMD
Market Cap
$5.57B$40.39B
Volume
1,926,4502,941,009
Sector
Consumer CyclicalHealth
52-Week High
$24.47$221.15
52-Week Low
$16.09$49.56
Typical Hold Time
0 Days2 Days
Enterprise Value
$7.44B$37.09B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Jersey Mike's Subs Inc. Class A Common Stock

No Aura AI signal available yet.

Revolution Medicines Inc. Common Stock

Revolution Medicines (RVMD) trades at $188.44, down 2.84% on the day, amid a bearish technical signal. The company reported no revenue in 2025, with a net loss of $1.13 billion, and has missed earnings expectations for three consecutive quarters. However, recent positive developments include the start of a Phase 3 trial for RASONQUE in pancreatic cancer and FDA Breakthrough Therapy Designation, fueling analyst optimism.

The outlook balances high-risk, high-reward potential. Strong analyst support (91.67% buy ratings) and a $253.35 consensus price target suggest significant upside, driven by the promising oncology pipeline. Key risks include substantial cash burn, lack of current revenue, and clinical trial execution uncertainties, making the stock suitable for investors comfortable with biotech volatility.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

JMKE
100% Buy0% Sell
Avg holding period · 0 Days
RVMD
51% Buy49% Sell
Avg holding period · 2 Days

About Jersey Mike's Subs Inc. Class A Common Stock

Jersey Mike's Subs Inc. operates and franchises fast-casual submarine sandwich restaurants, with locations in US and Canada and franchise agreements extending to UK and Ireland.

Read more on JMKE →

About Revolution Medicines Inc. Common Stock

Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.

Read more on RVMD →